Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Calls for Better Safety Standards in Sports Medicine as NFL Clubs Face Drug-Practice Lawsuit
  • USA - English


News provided by

JoTo PR

Apr 03, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Bryn Wesch, Chief Financial Officer for Novus Medical Detox Center, Advocates for stronger regulations for pain meds in professional sports.
Bryn Wesch, Chief Financial Officer for Novus Medical Detox Center, Advocates for stronger regulations for pain meds in professional sports.

NEW PORT RICHEY, Fla. (PRWEB) April 03, 2017 -- The Washington Post recently revealed more than 1,800 former professional football players have filed a federal lawsuit against all 32 National Football League (NFL) clubs, claiming long-term health damage due to “improper and deceptive drug distribution practices by NFL teams.”(1) Novus Medical Detox Center, a leading Florida-based drug treatment facility, says the case underscores serious ethical conflicts in sports medicine and calls for new safety and prescribing guidelines to preserve athletes’ health.

While sports organizations have an interest in protecting their investment, they also have a moral obligation not to compromise players’ health or safety.

Post this

According to the court filings, the average NFL team prescribed nearly 5,777 doses of nonsteroidal anti-inflammatory drugs (NSAIDs) and 2,213 doses of controlled medications during the 2012 calendar year. One trainer testified that doctors gave players injections of prescription drugs “without telling them what the drug was they were receiving or its side effects.” Every physician deposed admitted to violating one or more federal drug laws/regulations, and lawyers assert that the clubs’ doctors and trainers “concealed their illegal activities for years.”(1)

Among the medications of concern are Toradol, an injectable NSAID that deadens feeling and inhibits the ability to sense pain, and opioids such as Vicodin, which also mask pain but are highly addictive.(1) Athletes who use Toradol while playing may unknowingly cause further damage, and the drug is associated with renal toxicity and concussion risk.(2) Prescription opioids not only have the potential to increase and prolong pain,(3) but they can lead to substance use disorders. One study found that 52% of retired NFL players used opioids during their football career, and 71% of them admitted to misusing the drugs. The researchers also noted that 7% of all retired NFL players continue to misuse opioids, and those who used opioids during their careers reported worse current health than those who did not.(4)

“Professional athletes are at risk for serious long-term health issues; and as this court case shows, the continuing ethical conflicts and lack of standards can have devastating consequences for players’ future wellbeing,” warned Bryn Wesch, CFO of Novus Medical Detox Center. “Without clear guidelines or league-supported best practices in place, these athletes must endure enormous pressure and difficult decisions—do they protect their health at the risk of their career, or do they prioritize the team’s short-term success over their long-term health and safety?”

Wesch acknowledges that team physicians face a difficult dilemma, having to balance their employers’ concern for “team health” and success against the health and wellbeing of individual athletes.(2) Without set standards, team physicians must rely on their own clinical judgment but are also subject to the influence of their employers’ demands. Citing the positive strides the NFL’s concussion protocol has contributed to players’ health and safety,(5) Wesch believes professional sports leagues should define and implement new standards that address drug prescribing and administration practices as well as players’ rights concerning long-term health consequences.

“While sports organizations have an interest in protecting their investment, they also have a moral obligation not to compromise players’ health or safety,” stated Wesch. “As a provider of medically supervised detox programs, Novus has seen firsthand how irresponsible prescribing practices can adversely impact patients’ health and lead to substance use disorders that put their very lives at risk. Athletes should be allowed to heal properly from their injuries rather than having drugs pushed on them so they can play through their pain. We will continue to advocate for sports-medicine guidelines that: prioritize players’ welfare; mandate responsible drug-prescribing practices; address potential substance use disorders; and ensure access to drug treatment programs.”

For more information on Novus Medical Detox Center and its prescription drug treatment programs, visit https://novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center has earned The Joint Commission’s Gold Seal of Approval for Behavioral Health Care Accreditation as an inpatient medical detox facility. Licensed by the Florida Department of Children and Families, Novus provides safe, effective alcohol and drug treatment programs that are based on proven medical protocols and designed to minimize the discomfort of withdrawal. The facility is located on 3.25 acres in New Port Richey, Florida, in a tranquil, spa-like setting bordering protected conservation land. Intent on proving that detox doesn’t have to be painful or degrading, Novus set out to transform the industry by bringing humanity into medical detox with individually customized treatment programs and 24/7 access to nursing care and withdrawal specialists. Today, Novus is renowned as a champion of industry standardization and a staunch advocate of patients fighting to overcome substance use disorders. Frequently recognized for its contributions to the industry and local community, Novus has become a regular source to media publications such as The Wall Street Journal and USA Today, and has ranked in the Tampa Bay Business Journal’s Fast 50, the Florida Business Journal’s Top 500 and the Inc. 5000 list of America’s fastest-growing companies. For more information on Novus’ medically supervised detox programs, visit https://novusdetox.com.

1. Maese, Rick. “NFL Abuse of Painkillers and Other Drugs Described in Court Filings”; The Washington Post; March 9, 2017. washingtonpost.com/sports/redskins/nfl-abuse-of-painkillers-and-other-drugs-described-in-court-filings/2017/03/09/be1a71d8-035a-11e7-ad5b-d22680e18d10_story.html

2. Testoni, Daniela; Christoph P. Hornik; et al. “Sports Medicine and Ethics”; American Journal of Bioethics; January 23, 2014. ncbi.nlm.nih.gov/pmc/articles/PMC3899648/

3. Grace, Peter M.; Keith A. Strand; et al. “Morphine Paradoxically Prolongs Neuropathic Pain in Rats by Amplifying Spinal NLRP3 Inflammasome Activation”; Proceedings of the National Academy of Sciences; June 14, 2016. pnas.org/content/113/24/E3441.abstract

4. Cottler, Linda B.; Arbi Ben Abdallah; et al. “Injury, Pain, and Prescription Opioid Use Among Former National Football League (NFL) Players”; Drug and Alcohol Dependence; July 1, 2011. ncbi.nlm.nih.gov/pmc/articles/PMC3095672/

5. Stites, Adam. “How Does the NFL’s Concussion Protocol Work?”; SB Nation; January 8, 2017. sbnation.com/nfl/2016/9/18/12940926/nfl-concussion-protocol-explained

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.